Company: SMNR
Filing Date: 2025-08-22
Form Type: DEFA14A
Source: 0001213900-25-079507
Chunk: 8

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: DEFA14A
Chunk 8
---
 such Buyer’s name in column (3) on the Schedule of Buyers (the “ Closing”).

(b) Closing. The date and time of the Closing (the “ Closing Date”) shall be the date and time of the closing of the Business Combination, subject to notification of satisfaction (or waiver) of the conditions to the Closing set forth in Sections 6 and 7 below, remotely by electronic transfer of Closing documentation.

(c) Purchase Price. The purchase price for the Common Shares to be purchased by each Buyer pursuant to this Agreement shall be $16.00 per Common Share (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassification, combinations, reverse stock splits or other similar events occurring after the date hereof), with the aggregate purchase price for the Common Shares to be purchased by each Buyer to be the amount set forth opposite such Buyer’s name in column (4) of the Schedule of Buyers (the “ Purchase Price”).

(d) Form of Payment. On the Closing Date, (i) each Buyer shall pay its respective Purchase Price to Denali (as New Semnur) for the Common Shares to be issued and sold to such Buyer pursuant to this Agreement by wire transfer of immediately available funds in accordance with Denali’s written wire instructions and (ii) Denali (as New Semnur) shall deliver to each Buyer the number of Common Shares such Buyer is purchasing as is set forth opposite such Buyer’s name in column (3) of the Schedule of Buyers.

(e) Deposit Shares. No earlier than the Closing Date and no later than the date that is twenty (20) business days following the Closing, Semnur shall cause to be deposited into an escrow account in the name of the Escrow Agent (as defined below) an aggregate of 12,000,000 shares (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassification, combinations, reverse stock splits or other similar events occurring after the date hereof) of New Semnur Common Stock (the “ Escrow Shares”) held by Scilex, Inc. (the parent company of Semnur) in accordance with the terms of a Securities Escrow Agreement to be entered into between Semnur, the Buyers and an escrow agent mutually agreeable to the holders of at least a majority of the aggregate amount of Common Shares issued and issuable hereunder (the “ Majority Purchasers”) and Semnur (the “ Escrow Agent”). The “ Securities